Advancing Innovation in Gastroenterology & Liver Research
At CIBRA — the clinical research arm of Continental Hospitals — we specialize in ethically sound, patient-centric trials across liver and digestive health, hepatology, liver transplantation, and oncology. Our services reflect a commitment to precision science, compassionate care, and global compliance.
Clinical Trials (Phase I–IV)
We conduct early to late-phase studies focused on real-world outcomes, scientific rigor, and regulatory compliance (ICH-GCP, FDA, DCGI). Our trials cover a wide spectrum—from first-in-human to post-marketing surveillance—across GI, liver, and cancer therapies.
Gastrointestinal Research
Focused on advancing treatments for Inflammatory Bowel Disease (IBD), NASH, and GI cancers, our research targets conditions like Crohn’s, ulcerative colitis, GERD, and functional GI disorders, aiming to improve digestive health outcomes globally.
Liver Disease Research
We specialize in trials for Hepatitis B/C, cirrhosis, liver fibrosis, and liver transplantation outcomes, with dedicated protocols to improve diagnostics, treatments, and transplant success rates.
Biomarker Discovery & Validation
Our scientific team works to identify and validate biomarkers that aid in early detection, treatment precision, and monitoring of GI, hepatic, and oncologic conditions—bridging laboratory innovation with clinical outcomes.
Research Partnerships
CIBRA is trusted by global CROs, pharmaceutical companies, and academic institutions. We provide an agile, compliant, and collaborative research environment for seamless project execution and accelerated innovation.
Patient-Centered Clinical Studies
Our research is designed with patients at the core—ensuring clarity, comfort, and consent at every step. From enrollment to follow-up, we uphold compassion, ethics, and excellence in every clinical journey.




About CIBRA (Continental Institute of Biomedical Research and Analytics)
CIBRA is the dedicated clinical research institute of Continental Hospitals, Hyderabad, specializing in ethically driven, patient-centric clinical trials across digestive health, hepatology, liver transplantation, and oncology.
With a commitment to clinical excellence and compassionate care, our team of board-certified investigators and research professionals leads globally compliant trials (ICH-GCP, FDA, DCGI) designed to shape the future of medicine.
- Board-Certified Investigators
- Gastroenterology & Liver Focus
- Patient-Centered Approach
- FDA & GCP Compliant
- Trusted Research Partner

-
Clinical Research Excellence
-
Patient-First Study Design
-
FDA & GCP Compliant
-
Gastroenterology Innovations
-
Liver Disease Research
-
Trusted Research Partnerships
-
Clinical Research Excellence
-
Patient-First Study Design
-
FDA & GCP Compliant
-
Gastroenterology Innovations
-
Liver Disease Research
-
Trusted Research Partnerships